Unregistered Sales of Equity Securities and Use of Proceeds.
−Removed: November 23, 2021, the Company consummated the Initial Public Offering of 17,391,200 units at $10.00 per Unit and the sale of 7,032,580
−Removed: Private Placement Warrants at a price of $1.00 per Private Placement Warrant in a private placement to the Sponsor that closed simultaneously
−Removed: with the closing of the Initial Public Offering.
−Removed: The Company has listed the Units on the New York Stock Exchange.
−Removed: On November 23, 2021,
−Removed: the underwriters exercised their over-allotment option in full, according to which the Company consummated the sale of an additional
−Removed: 2,608,680 Units, at $10.00 per Unit, and the sale of an additional 764,262 Private Placement Warrants, at $1.00 per Private Placement
−Removed: Following the closing of the over-allotment option, the Company generated total gross proceeds of $207,795,642 from the Initial
−Removed: Public Offering and the Private Placement, of which the Company raised $199,998,800 in the Initial Public Offering, $7,796,842 in the
−Removed: Private Placement and of which $202,998,782 was placed in the Company’s Trust Account with Continental Stock Transfer & Company
−Removed: as trustee, established for the benefit of the Company’s public shareholders.
−Removed: Transaction costs amounted to $9,351,106 consisting
−Removed: of $2,499,985 of underwriting fees, $5,999,964 was for deferred underwriting commissions, $268,617 for the fair value of the representative
−Removed: shares and $582,540 of other offering costs .
−Removed: The amount of funds available for a business combination is approximately $ 53.2
−Removed: million after payment of $5,999,964 of deferred underwriting fees and payment of an aggregate redemption amount of approximately
−Removed: $109.31 million as a result of the approval of the First Extension Proposal, and an aggregate redemption amount of approximately $23.8
−Removed: million as a result of the approval of the Second Extension Proposal and an aggregate redemption amount of approximately $30.26 million
−Removed: as a result of the approval of the Third Extension Proposal.
−Removed: a description of the use of the proceeds generated in the Initial Public Offering, see Part I, Item 2 of this Quarterly Report.
+Added: During the quarter ended September 30, 2024, there were no unregistered sales of our securities that were not reported in a Current Report
+Added: At the closing of the Business Combination, $56.0 million remained in the Company’s trust account, of which $54.8 million was used
+Added: to pay public shareholders who exercised redemption rights, $0.8 million was used to pay outstanding fees and expenses of INFINT incurred
+Added: in connection with the Business Combination, and $0.3 million was used to partially repay deferred underwriting fees, with no balance
+Added: remaining for working capital and general corporate purposes of Currenc.
+Added: with the closing of the Business Combination, Currenc completed the PIPE Offering, resulted in gross proceeds of $1.75 million, of which
+Added: $0.8 million was used to pay outstanding fees and expenses of INFINT, $0.5 million was used to pay a directors and officers insurance
+Added: premium, and $0.4 million was used to pay outstanding fees and expenses of Seamless.
Defaults Upon Senior Securities.
1 unchanged sentence
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.